Skip to content
Subcommittee on Antitrust, Monopolies and Business Rights

Marketing of Clozaril: Improved Safety or Barrier to Access

Type: Subcommittee Hearing
Date:
Time: 09:30am
Location: Dirksen Senate Office Building Room 226

Panel 1

  • Kevin J. Arquit

    Director
    Bureau of Competition
    Federal Trade Commission
    Washington, DC
  • Paul Van Dam

    Attorney General
    State of Utah
    Salt Lake City, UT

Panel 2

  • Laurent S. Lehmann

    Associate Director for Psychiatry
    Department of Veterans Affairs
    Washington, DC
  • Howard M. Cullum

    Secretary
    Health and Human Resources
    Commonwealth of Virginia
    Richmond, VA
  • Mary Ellen Rehrman

    President
    Alliance for the Mentally Ill in Pennsylvania
    Spring City, PA